Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Mallinckrodt
Fuji
Moodys
US Department of Justice
Covington
Federal Trade Commission
Argus Health
AstraZeneca

Generated: April 24, 2018

DrugPatentWatch Database Preview

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

« Back to Dashboard

When do Cefepime And Dextrose In Duplex Container patents expire, and what generic alternatives are available?

Cefepime And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
Summary for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
Drug patent expirations by year for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
Pharmacology for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

US Patents and Regulatory Information for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER cefepime hydrochloride INJECTABLE;INJECTION 050821-001 May 6, 2010 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
B Braun CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER cefepime hydrochloride INJECTABLE;INJECTION 050821-002 May 6, 2010 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
Moodys
Mallinckrodt
Covington
AstraZeneca
Dow
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.